- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x TRP- EEP- ALA- DTH- CYS- HYP- ALA: Phalloidin(Non-covalent)
- 5 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
ADP.6: 17 residues within 4Å:- Chain A: G.14, S.15, G.16, L.17, K.19, G.157, D.158, R.211, K.214, E.215, G.302, G.303, T.304, M.306, Y.307, K.337
- Ligands: MG.7
13 PLIP interactions:13 interactions with chain A- Hydrogen bonds: A:S.15, A:G.16, A:L.17, A:L.17, A:D.158, A:D.158, A:D.158, A:K.214, A:G.303, A:K.337
- Salt bridges: A:K.19, A:K.19
- pi-Stacking: A:Y.307
ADP.8: 17 residues within 4Å:- Chain B: G.14, S.15, G.16, L.17, K.19, G.157, D.158, R.211, K.214, E.215, G.302, G.303, T.304, M.306, Y.307, K.337
- Ligands: MG.9
13 PLIP interactions:13 interactions with chain B- Hydrogen bonds: B:S.15, B:G.16, B:L.17, B:L.17, B:D.158, B:D.158, B:D.158, B:K.214, B:G.303, B:K.337
- Salt bridges: B:K.19, B:K.19
- pi-Stacking: B:Y.307
ADP.11: 17 residues within 4Å:- Chain C: G.14, S.15, G.16, L.17, K.19, G.157, D.158, R.211, K.214, E.215, G.302, G.303, T.304, M.306, Y.307, K.337
- Ligands: MG.10
13 PLIP interactions:13 interactions with chain C- Hydrogen bonds: C:S.15, C:G.16, C:L.17, C:L.17, C:D.158, C:D.158, C:D.158, C:K.214, C:G.303, C:K.337
- Salt bridges: C:K.19, C:K.19
- pi-Stacking: C:Y.307
ADP.12: 17 residues within 4Å:- Chain D: G.14, S.15, G.16, L.17, K.19, G.157, D.158, R.211, K.214, E.215, G.302, G.303, T.304, M.306, Y.307, K.337
- Ligands: MG.13
13 PLIP interactions:13 interactions with chain D- Hydrogen bonds: D:S.15, D:G.16, D:L.17, D:L.17, D:D.158, D:D.158, D:D.158, D:K.214, D:G.303, D:K.337
- Salt bridges: D:K.19, D:K.19
- pi-Stacking: D:Y.307
ADP.14: 17 residues within 4Å:- Chain E: G.14, S.15, G.16, L.17, K.19, G.157, D.158, R.211, K.214, E.215, G.302, G.303, T.304, M.306, Y.307, K.337
- Ligands: MG.15
13 PLIP interactions:13 interactions with chain E- Hydrogen bonds: E:G.14, E:S.15, E:G.16, E:L.17, E:D.158, E:D.158, E:D.158, E:K.214, E:G.303, E:K.337
- Salt bridges: E:K.19, E:K.19
- pi-Stacking: E:Y.307
- 5 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
MG.7: 2 residues within 4Å:- Chain A: Q.138
- Ligands: ADP.6
No protein-ligand interaction detected (PLIP)MG.9: 3 residues within 4Å:- Chain B: D.12, Q.138
- Ligands: ADP.8
No protein-ligand interaction detected (PLIP)MG.10: 2 residues within 4Å:- Chain C: Q.138
- Ligands: ADP.11
No protein-ligand interaction detected (PLIP)MG.13: 2 residues within 4Å:- Chain D: Q.138
- Ligands: ADP.12
No protein-ligand interaction detected (PLIP)MG.15: 1 residues within 4Å:- Ligands: ADP.14
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ceron, R.H. et al., Molecular mechanisms linking missense ACTG2 mutations to visceral myopathy. Sci Adv (2024)
- Release Date
- 2024-05-01
- Peptides
- Actin, gamma-enteric smooth muscle: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-pentamer
- Ligands
- 5 x TRP- EEP- ALA- DTH- CYS- HYP- ALA: Phalloidin(Non-covalent)
- 5 x ADP: ADENOSINE-5'-DIPHOSPHATE(Non-covalent)
- 5 x MG: MAGNESIUM ION(Non-covalent)(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Ceron, R.H. et al., Molecular mechanisms linking missense ACTG2 mutations to visceral myopathy. Sci Adv (2024)
- Release Date
- 2024-05-01
- Peptides
- Actin, gamma-enteric smooth muscle: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E